Filter your results
- 2
- 1
- 3
- 3
- 2
- 1
- 3
- 3
- 3
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML IntergroupBlood, 2014, 124 (8), pp.1312 - 1319. ⟨10.1182/blood-2014-01-549212⟩
Journal articles
hal-01688071v1
|
|||
|
Presence of calreticulin mutations in JAK2-negative polycythemia veraBlood, 2014, 124 (26), pp.3964-3966. ⟨10.1182/blood-2014-06-583161⟩
Journal articles
hal-03579004v1
|
||
|
Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.Haematologica, 2013, 98 (7), pp.1107-14. ⟨10.3324/haematol.2012.082412⟩
Journal articles
hal-00933219v1
|